Common Equity: The sum of all common equity items.
Kailera Therapeutics, Inc. (KLRA) had Common Equity of -432.09M for the most recently reported fiscal quarter, ending 2026-03-31.
| Income Statement Financials | |
-- |
|
-78.86M |
|
-- |
|
-- |
|
84.66M |
|
-84.66M |
|
5.79M |
|
-78.86M |
|
-78.86M |
|
-78.86M |
|
-78.86M |
|
-78.86M |
|
-78.86M |
|
-84.66M |
|
-84.56M |
|
0.02M |
|
0.02M |
|
-3650.00 |
|
-3650.00 |
|
| Balance Sheet Financials | |
530.32M |
|
1.85M |
|
94.44M |
|
624.76M |
|
54.84M |
|
-- |
|
9.64M |
|
64.48M |
|
|
Common Equity |
-432.09M |
560.28M |
|
560.28M |
|
0.03M |
|
| Cash Flow Statement Financials | |
-68.31M |
|
22.85M |
|
-2.98M |
|
161.03M |
|
112.59M |
|
-48.44M |
|
3.94M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
9.67 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-68.31M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
18.25% |
|
-14.08% |
|
-12.62% |
|
-14.08% |
|
0.02M |
|
-3161.47 |
|
-3161.47 |
|